Antibodies, Antibody Fragments, and Peptides: Targeting Muscular Diseases with RNA – Two Natural Capital
RNA therapeutics muscular diseases DMD DM1 delivery challenges Alnylam RNAi competition antibody peptide integrin targeting nuclear delivery clinical efficacy safety profiles anemia kidney dysfunction biotech investment analysis